PF-Atlas › Clinical Trials › NCT06567717

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Zinc · Phase 2

Registry ID

NCT06567717

Phase

Phase 2

Status

Recruiting

Drug / intervention

Zinc

Sponsor

Cedars-Sinai Medical Center

Start

2025-11-03

About this trial

Zinc is evaluated in NCT06567717, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Cedars-Sinai Medical Center. Current status: Recruiting.

View NCT06567717 on ClinicalTrials.gov →

Explore related

All Zinc trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT06567717 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.